Skip to content

Clinical trials

Immunoblastic Lymphadenopathy trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoblastic Lymphadenopathy Country / region: South Korea Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20092
20101
20171

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center2
Chonbuk National University Hospital1
Samsung Medical Center1
Singapore General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoblastic Lymphadenopathy5
Lymphoma, Large-Cell, Anaplastic5
Lymphoma, Extranodal NK-T-Cell3
Lymphoma, T-Cell3
Lymphoma, T-Cell, Cutaneous3
Blast Crisis2
Burkitt Lymphoma2
Congenital Abnormalities2
Hodgkin Disease2
Leukemia2

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.